18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
复制标题
DOI:
10.1016/s0140-6736(13)61754-7
复制
发表时间:
2014-02-22
期刊:
影响因子:
168.9
通讯作者:
Newby, David E.
中科院分区:
文献类型:
--
作者:
Joshi, Nikhil V.;Vesey, Alex T.;Newby, David E.
Background The use of non-invasive imaging to identify ruptured or high-risk coronary atherosclerotic plaques would represent a major clinical advance for prevention and treatment of coronary artery disease. We used combined PET and CT to identify ruptured and high-risk atherosclerotic plaques using the radioactive tracers F-18-sodium fluoride (F-18-NaF) and F-18-fluorodeoxyglucose (F-18-FDG).Methods In this prospective clinical trial, patients with myocardial infarction (n=40) and stable angina (n=40) underwent F-18-NaF and F-18-FDG PET-CT, and invasive coronary angiography. F-18-NaF uptake was compared with histology in carotid endarterectomy specimens from patients with symptomatic carotid disease, and with intravascular ultrasound in patients with stable angina. The primary endpoint was the comparison of F-18-fluoride tissue-to-background ratios of culprit and non-culprit coronary plaques of patients with acute myocardial infarction.Findings In 37 (93%) patients with myocardial infarction, the highest coronary F-18-NaF uptake was seen in the culprit plaque (median maximum tissue-to-background ratio: culprit 1.66 [IQR 1.40-2.25] vs highest non-culprit 1.24 [1.06-1.38], p